Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2002 Canadian Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: 1st.mate who wrote (589)	3/26/2002 5:37:30 PM
From: Canuck Dave	Read Replies (2) \| Respond to of 1590

I bought some SWG (for real). That's why it's doing nothing, LOL. I only bought it to frustrate you and marcos. Some stocks you have zero luck with. Then, there's ones like FGX.... Good luck with your new pick. CD

To: 1st.mate who wrote (589)	3/27/2002 12:31:56 AM
From: Al Collard	Read Replies (1) \| Respond to of 1590

Hi Matey, You sold: SWG-t @$ 2.97 X 7,518 shares = $22,328.46 You bought: HML-t @$ 5.00 = 4,465 shares = $22,325.00 Good luck with your new pick Matey, Al

To: 1st.mate who wrote (589)	3/28/2002 12:30:38 AM
From: Al Collard	Respond to of 1590

HML-t...in the news: Hemosol raises $15-million in bought deal Wed 27 Mar 2002 Mr. Jason Hogan reports HEMOSOL ENTERS AGREEMENT FOR $15 MILLION BOUGHT DEAL Hemosol has entered into a bought deal agreement with a syndicate of underwriters co-led by Sprott Securities Inc. and Yorkton Securities Inc. Under the terms of the agreement, the underwriters have agreed to purchase 3.35 million units of the company at a price of $4.50 per unit, resulting in gross proceeds of $15,075,000. In addition, the company has granted the underwriters an option to purchase an additional 1.12 million units of the company at an offering price of $4.50 per unit for a period ending 48 hours prior to closing. Each unit consists of one common share of the company plus one-half of one purchase warrant where each purchase warrant is exercisable into one common share at a price of $5.50 per common share for a period of one year. The warrants are subject to redemption at nominal consideration six months after closing if the share price is greater than $8.00 for 20 consecutive trading days. Hemosol is currently negotiating certain amendments to its $35-million senior credit facility as a result of the extensions of the time lines for regulatory approvals of Hemolink (hemoglobin raffimer). Until these amendments are in place the company will not be in a position to draw down on the facility. The closing of the offering is conditional upon the company reaching agreement with the senior lenders as to the appropriate amendments to the senior credit facility. The offering is expected to close on or about April 17, 2002. The net proceeds of the offering will be used to finance continuing clinical trials and for general working capital purposes. The transaction is subject to the receipt of all necessary regulatory and stock exchange purposes.

To: 1st.mate who wrote (589)	3/28/2002 12:39:23 PM
From: Al Collard	Read Replies (1) \| Respond to of 1590

HML-t...in the news: Hemosol Enters Agreement to Increase Bought Deal to $22 Million newswire.ca

To: 1st.mate who wrote (589)	4/11/2002 4:56:21 PM
From: Al Collard	Respond to of 1590

HML-t...in the news: Hemosol Files Final Prospectus For Public Offering And Amends Senior Credit Facility newswire.ca

To: 1st.mate who wrote (589)	4/15/2002 7:05:15 AM
From: Al Collard	Respond to of 1590

HML-t...in the news: Hemosol Announces Webcast of First Quarter 2002 Conference Call newswire.ca

To: 1st.mate who wrote (589)	4/18/2002 10:46:15 PM
From: Al Collard	Read Replies (1) \| Respond to of 1590

HML-t...in the news: Hemosol to list 2.45 million warrants on TSE Thu 18 Apr 2002 TSE bulletin 2002-0442 A total of 2.45 million common share purchase warrants of Hemosol Inc. will be listed and posted for trading at the open on Monday, April 22, 2002, under the following trading information: Symbol: HML.WT Cusip No: 42369K 13 6 Designated market-maP. Barker, W.D. Latimer Co. Limited Other markets: None The warrants are being issued in connection with a recently completed prospectus offering of units by the company, each unit consisting of one common share and one-half of a warrant. Details of the prospectus offering are contained elsewhere in today's exchange bulletins. Each whole warrant entitles the holder to purchase one common share of the company at a price of $5.50 in cash per share until 5 p.m. (Toronto time) on April 18, 2003. If, at any time after Oct. 18, 2002, the closing price of the company's common shares on the Toronto Stock Exchange for any 20 consecutive trading days is greater than $8 per share, the company may redeem the warrants, on not less than 30 days of prior notice, for a redemption price of 0.001 cent per warrant. The warrants are governed by the terms of a warrant indenture dated April 18, 2002, between the company and Computershare Trust Company of Canada, as trustee. The warrant indenture provides for appropriate adjustments to the warrants in the event of stock dividends, subdivisions, consolidations and other forms of capital reorganization.

To: 1st.mate who wrote (589)	4/25/2002 7:49:29 AM
From: Al Collard	Respond to of 1590

HML-t...in the news: Hemosol Announces First Quarter 2002 Financial Results newswire.ca